PortfoliosLab logo

AVEO Pharmaceuticals, Inc. (AVEO)

Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US0535883070
CUSIP
053588307

AVEOPrice Chart


Chart placeholderClick Calculate to get results

AVEOPerformance

The chart shows the growth of $10,000 invested in AVEO Pharmaceuticals, Inc. on Mar 15, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $380 for a total return of roughly -96.20%. All prices are adjusted for splits and dividends.


AVEO (AVEO Pharmaceuticals, Inc.)
Benchmark (S&P 500)

AVEOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-27.08%-7.73%
1M-33.20%-5.40%
6M-35.10%0.70%
1Y-60.14%14.18%
5Y-12.84%14.13%
10Y-31.22%12.86%

AVEOMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AVEOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current AVEO Pharmaceuticals, Inc. Sharpe ratio is -0.48. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


AVEO (AVEO Pharmaceuticals, Inc.)
Benchmark (S&P 500)

AVEODividends


AVEO Pharmaceuticals, Inc. doesn't pay dividends

AVEODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AVEO (AVEO Pharmaceuticals, Inc.)
Benchmark (S&P 500)

AVEOWorst Drawdowns

The table below shows the maximum drawdowns of the AVEO Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AVEO Pharmaceuticals, Inc. is 98.75%, recorded on Mar 18, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.75%Jul 22, 20112177Mar 18, 2020
-36.6%Apr 22, 201063Jul 21, 201046Sep 24, 2010109
-24.99%Nov 9, 2010100Apr 1, 201129May 13, 2011129
-14.31%Jun 3, 201111Jun 17, 20116Jun 27, 201117
-9%Oct 12, 201013Oct 28, 20105Nov 4, 201018
-7.26%Apr 13, 20101Apr 13, 20106Apr 21, 20107
-6.91%May 19, 20118May 31, 20112Jun 2, 201110
-5%Mar 16, 20108Mar 25, 20105Apr 1, 201013
-3.66%Jul 12, 20113Jul 14, 20115Jul 21, 20118
-2.52%Jun 30, 20112Jul 1, 20111Jul 5, 20113

AVEOVolatility Chart

Current AVEO Pharmaceuticals, Inc. volatility is 45.32%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AVEO (AVEO Pharmaceuticals, Inc.)
Benchmark (S&P 500)

Portfolios with AVEO Pharmaceuticals, Inc.


Loading data...

More Tools for AVEO Pharmaceuticals, Inc.